Hypertension: A Companion to Braunwald’s Heart Disease book cover

Hypertension: A Companion to Braunwald’s Heart Disease

,

Published: November 2006

Imprint: Saunders

ISBN: 978-1-4160-3053-9

Contents




  • Section 1: Epidemiology & Pathophysiology

    1. Epidemiology
    2. Genetics of Hypertension
    3. Pathogenesis of Hypertension

    Section 2: Diagnosis

    4. Definition of Hypertension
    5. Measurement of Blood
    6. Home BP Measurements
    7. ABPM
    8. Secondary Hypertension: Renovascular Hypertension
    9. Secondary Hypertension: Mineralocorticoid Excess States
    10. Secondary Hypertension: Pheochromocytoma
    11. Secondary Hypertension: Sleep Apnea
    12. Rare Unusual Diagnoses


    Section 3: Risk Stratification

    13. Natural History of (Untreated) Hypertension
    14. The Special Problem of (Isolated) Systolic Hypertension
    15. Assessment of Target Organ Damage
    16. Prediction of Global Cardiovascular Risk


    Section 4: Treatment

    17. Lifestyle Modifications
    18. Diuretics
    19. Beta-blockers
    20. ACE-inhibitors and Angiotensin II Receptor Blockers
    21. Calcium Antagonists
    22. Alpha-Blockers
    23. Other (Newer) Drugs, including centrally-acting drugs, aldosterone antagonists, vasopeptidase inhibitors, and endothelin antagonists


    Section 5: Outcome Studies

    24. Design of Outcomes Studies
    25. Meta-analyses


    Section 6: Hypertension and Concomitant Diseases

    26. Ischemic Heart Disease
    27. Heart Failure
    28. Kidney Disease
    29. Transplant Hypertension
    30. Obesity
    31. Peripheral Vascular Disease
    32. Cerebrovascular Disease
    33. Diabetes
    34. Dyslipidemia


    Section 7: Special Populations & Special Situations

    35. Pregnancy-Related Hypertension
    36. Children and Adolescents
    37. Elderly
    38. Blacks
    39. Hispanics
    40. East Asians
    41. South Asians
    42. Refractory Hypertension
    43. Peri-operative Hypertension
    44. Emergencies and Urgencies


    Section 8: Hypertension Treatment in the Future

    45. Hypertension Disease Management Service
    46. Hypertension Genomics
    47. Approval Process for Antihypertensive Drugs—US and International


    Section 9: Guidelines

    48. US and Canadian Guidelines
    49. European Guidelines, including BHS and ESH/ESC

Advertisement

advert image